Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2

ABSTRACT:

SUBMITTER: Raig N 

PROVIDER: S-EPMC12136037 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature